Category: BioTech

Blood

European health giant snaps up BioTech in £1bn deal

A Cambridge biopharmaceutical company has been acquired in a deal potentially worth £1 billion by ...

Brain

Origami-engineered device ‘could prevent brain haemorrhage’

An Oxford University spin-out has raised £7.3 million to develop a device which could prevent brai...

Dr Gordon Sanghera, Oxford Nanopore

BioTech behind COVID-19 tracking to float in London

Oxford Nanopore Technologies has revealed plans to float on the London Stock Exchange later this ...

Bovine TB

Can BioTech halt disease which has led to slaughter of 300,000 cattle?

A BioTech company which has developed a rapid test that could be a ‘game-changer’ in combating...

Sirona, Oxford Medical Products

Tech-enabled weight loss capsule is ‘safe and affordable’

Oxford Medical Products has raised £1.2 million to develop a weight loss technology which could hel...

(l-r) John Davies and Matt Currie, Seneca Partners 

Finance firm Seneca hits £100m investment milestone

North West finance firm Seneca Partners is celebrating a significant milestone after investing £100...

Dr Chris Torrance, PhoreMost

BioTech PhoreMost raises £33m to target ‘undruggable’ diseases

PhoreMost, a biopharmaceutical company dedicated to ‘drugging the undruggable’ disease targets...

CytoSeek CEO Dr Carolyn Porter

Tech to kill solid cancer tumours backed by new fund

University of Bristol spin-out CytoSeek has raised a £3.5 million seed round to develop new cell t...

Cancer cell

BioTech ‘to speed up cancer drug discovery from years to weeks’

A biotechnology company hopes to speed up the drug discovery development timetable for cancer and ...

DNA

New financing for cancer-fighting DNA start-up NeoPhore

A BioTech which effectively forces cancer cells to reveal themselves to patients’ immune syste...

Insights

View All